This study evaluated the responses of 10 pharmaceutical companies to drug information questions on 10 of their drugs via a telephone survey. For each drug, one question addressed the following topics: general information, drug interaction, dosing in special populations, mechanism of action/pharmacokinetics, stability/storage, off-label use, and adverse events. Overall satisfaction with the verbal and written responses was 65% and 70%, respectively. Eighty-four percent of the callers found the written responses useful and 66% found the verbal responses useful. Health care professionals were most concerned with finding an answer to their question and less concerned with call handling. The following best practices were identified: using the caller’s name in conversation, repeating the question for accurate understanding, asking more questions to elicit further information, summarizing the discussion, and sending timely written follow-up responses. An objective for the pharmaceutical industry is to convert written responses to more useful verbal responses.
[1]
Jay H. Bauman,et al.
Evaluation and Effectiveness of a Pharmaceutical-Based Drug Information Service
,
1994
.
[2]
Fred J. Salter,et al.
Management of Drug Information Inquiries from Health Care Professionals: An Industry-Wide Survey
,
1986
.
[3]
J. Generali,et al.
A Comparison of Pharmaceutical Manufacturers as a Source of Drug Information to a Telephone Inquiry: Generic vs Brand
,
1983,
Drug information journal.
[4]
W. Kelly,et al.
Drug Information Centers: Lack of Generic Equivalence
,
1977,
Drug intelligence & clinical pharmacy.